These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12510010)

  • 1. Hypothalamic-pituitary adrenal response to cholecystokinin-B receptor agonism is resistant to cortisol feedback inhibition.
    Abelson JL; Young EA
    Psychoneuroendocrinology; 2003 Feb; 28(2):169-80. PubMed ID: 12510010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose response of adrenocorticotropin and cortisol to the CCK-B agonist pentagastrin.
    Abelson JL; Liberzon I
    Neuropsychopharmacology; 1999 Oct; 21(4):485-94. PubMed ID: 10481831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of the regulation of the hypothalamo-pituitary-adrenal (HPA) axis determined using a nonsurgical method for collecting pituitary venous blood from horses.
    Alexander SL; Irvine CH; Donald RA
    Front Neuroendocrinol; 1996 Jan; 17(1):1-50. PubMed ID: 8788568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased hypothalamic-pituitary-adrenal axis sensitivity to cortisol feedback inhibition in human aging.
    Wilkinson CW; Peskind ER; Raskind MA
    Neuroendocrinology; 1997 Jan; 65(1):79-90. PubMed ID: 9032777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.
    Grottoli S; Giordano R; Maccagno B; Pellegrino M; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4616-20. PubMed ID: 12364444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.
    Berardelli R; Karamouzis I; Marinazzo E; Prats E; Picu A; Giordano R; Ghigo E; Arvat E
    Eur J Endocrinol; 2010 Jun; 162(6):1067-74. PubMed ID: 20219855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of repeat exposure on neuroendocrine and symptom responses to pentagastrin.
    Khan S; Liberzon I; Abelson JL
    Psychiatry Res; 2004 May; 126(3):189-95. PubMed ID: 15157745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feedback sensitivity of the rat hypothalamo-pituitary-adrenal axis and its capacity to adjust to exogenous corticosterone.
    Akana SF; Scribner KA; Bradbury MJ; Strack AM; Walker CD; Dallman MF
    Endocrinology; 1992 Aug; 131(2):585-94. PubMed ID: 1322275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cortisol treatment on brain and adrenal corticotropin-releasing hormone (CRH) content and other parameters regulated by CRH.
    Bagdy G; Calogero AE; Szemeredi K; Chrousos GP; Gold PW
    Regul Pept; 1990 Nov; 31(2):83-92. PubMed ID: 2176309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose response of arginine vasopressin to the CCK-B agonist pentagastrin.
    Abelson JL; Le Mellédo J; Bichet DG
    Neuropsychopharmacology; 2001 Feb; 24(2):161-9. PubMed ID: 11120398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antalarmin, a novel corticotropin-releasing hormone antagonist, on the dynamic function of the preterm ovine fetal hypothalamo-pituitary-adrenal axis.
    Young IR; Chan EC; Smith R; Chrousos GP; Veldhuis JD; Canny BJ
    Neuroendocrinology; 2002 Jul; 76(1):47-54. PubMed ID: 12097816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
    Tizabi Y; Aguilera G
    Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on circadian rhythm and the feedback mechanism of hormone secretion from the hypothalamic-pituitary-adrenal system --pertaining to the circadian variation of feedback sensitivity in the hypothalamic-pituitary axis-- (author's transl)].
    Kamijo K; Suzuki M; Oara H; Wada T
    Nihon Naibunpi Gakkai Zasshi; 1975 Apr; 51(4):209-17. PubMed ID: 169169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
    Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
    J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoid receptor blockade by canrenoate increases both spontaneous and stimulated adrenal function in humans.
    Arvat E; Maccagno B; Giordano R; Pellegrino M; Broglio F; Gianotti L; Maccario M; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3176-81. PubMed ID: 11443185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
    van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
    Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man.
    Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
    J Clin Endocrinol Metab; 1993 Feb; 76(2):388-91. PubMed ID: 8381800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin-octapeptide stimulates hypothalamic-pituitary-adrenal function in rats: role of corticotropin-releasing hormone.
    Kamilaris TC; Johnson EO; Calogero AE; Kalogeras KT; Bernardini R; Chrousos GP; Gold PW
    Endocrinology; 1992 Apr; 130(4):1764-74. PubMed ID: 1312423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.